Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Treace Medical Concepts, Inc. - Common Stock (NQ:TMCI)

6.450 -0.070 (-1.07%)
Official Closing Price Updated: 4:15 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 406,716
Open 6.470
Bid (Size) 6.420 (1)
Ask (Size) 8.970 (3)
Prev. Close 6.520
Today's Range 6.400 - 6.600
52wk Range 3.920 - 11.51
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TMCI
From The Rosen Law Firm PA
Via GlobeNewswire
Law Offices of Frank R. Cruz Encourages Treace Medical Concepts, Inc. (TMCI) Investors To Inquire About Securities Fraud Class Action
From Law Offices of Frank R. Cruz
Via Business Wire

Performance

YTD
-18.0%
-18.0%
1 Month
-21.5%
-21.5%
3 Month
-30.4%
-30.4%
6 Month
+20.3%
+20.3%
1 Year
-41.2%
-41.2%

More News

Read More
TMCI Stockholder Notice: Robbins LLP Reminds Shareholders of the Class Action Lawsuit Against Treace Medical Concepts, Inc.
From Robbins LLP
Via GlobeNewswire
Deep Dive Into Treace Medical Concepts Stock: Analyst Perspectives (4 Ratings)
Via Benzinga
Earnings Scheduled For February 27, 2025
Via Benzinga
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
From Pomerantz LLP
Via GlobeNewswire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Treace Medical Concepts, Inc. (TMCI) Investors To Inquire About Securities Fraud Class Action
From Glancy Prongay & Murray LLP
Via Business Wire
Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of BioAge Labs, Inc. (NASDAQ: BIOA); NAPCO Security Technologies, Inc. (NASDAQ: NSSC); Treace Medical Concepts, Inc. (NASDAQ: TMCI); and Virtu Financial Inc. (NASDAQ: VIRT)
From Grabar Law Office
Via GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TMCI
From The Rosen Law Firm PA
Via GlobeNewswire
Law Offices of Howard G. Smith Encourages Treace Medical Concepts, Inc. (TMCI) Investors To Inquire About Securities Fraud Class Action
From Law Offices of Howard G. Smith
Via Business Wire
TREACE MEDICAL CONCEPTS, INC. (NASDAQ: TMCI) INVESTOR ALERT: Investors With Large Losses in Treace Medical Concepts, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
From Bernstein Liebhard LLP
Via GlobeNewswire
TMCI Investors Have the Opportunity to Lead the Treace Medical Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
From Faruqi & Faruqi LLP
Via GlobeNewswire
Rosen Law Firm Urges Treace Medical Concepts, Inc. (NASDAQ: TMCI) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical
From Faruqi & Faruqi LLP
Via GlobeNewswire
Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Treace Medical Concepts, Inc. (NASDAQ: TMCI)
From Scott+Scott Attorneys at Law LLP
Via Business Wire
Treace Highlights New Innovations at the 2025 ACFAS Annual Scientific Conference
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Announces Upcoming Board Chair Transition
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Get insights into the top gainers and losers of Friday's pre-market session.
Via Chartmill
Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 ACFAS Annual Scientific Conference
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2024 Financial Results
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Why Pinterest Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Treace to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Announces First Surgical Cases Utilizing the SpeedAkin™ Anatomic Compression Implant
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Why INNOVATE Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket
Via Benzinga

Frequently Asked Questions

Is Treace Medical Concepts, Inc. - Common Stock publicly traded?
Yes, Treace Medical Concepts, Inc. - Common Stock is publicly traded.
What exchange does Treace Medical Concepts, Inc. - Common Stock trade on?
Treace Medical Concepts, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Treace Medical Concepts, Inc. - Common Stock?
The ticker symbol for Treace Medical Concepts, Inc. - Common Stock is TMCI on the Nasdaq Stock Market
What is the current price of Treace Medical Concepts, Inc. - Common Stock?
The current price of Treace Medical Concepts, Inc. - Common Stock is 6.450
When was Treace Medical Concepts, Inc. - Common Stock last traded?
The last trade of Treace Medical Concepts, Inc. - Common Stock was at 04/17/25 04:15 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.